Similar Articles
691 Hepatocellular carcinoma – time to take the ticket
692 Biomarkers vs imaging in the early detection of hepatocellular carcinoma and prognosis
693 Expression of genes that control core fucosylation in hepatocellular carcinoma: Systematic review
694 Liver transplantation for hepatocellular carcinoma: Where do we stand?
695 Gadoxetic acid-enhanced magnetic resonance imaging can predict the pathologic stage of solitary hepatocellular carcinoma
696 Optimizing radiotherapy with immune checkpoint blockade in hepatocellular carcinoma
697 Mechanisms of hepatocellular carcinoma progression
698 Change in arterial tumor perfusion is an early biomarker of lenvatinib efficacy in patients with unresectable hepatocellular carcinoma
699 Stereotactic body radiation therapy in patients with hepatocellular carcinoma: A mini-review
700 ADAMTS13 and von Willebrand factor are useful biomarkers for sorafenib treatment efficiency in patients with hepatocellular carcinoma
© 2004-2025 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA